Michael Muntner is a Partner based in New York who co-founded the firm’s healthcare services & technology practice. He has over 25 years of investment-banking experience, having advised on over $400 billion of transactions, including some of the largest healthcare-services deals ever.
Selected advisory assignments include:
Payors and Value-Based Care
• CVS Health on its $78 billion acquisition of Aetna
• Express Scripts on its $67 billion sale to Cigna
• Oak Street Health on its $11 billion sale to CVS Health
• Cigna on the $3.7 billion sale of its Medicare Businesses and CareAllies to HCSC
• Landmark Health on its sale to UnitedHealth
• DentaQuest on its $2.5 billion sale to Sun Life Financial
• HealthSun on its sale to Elevance Health
• CareBridge on its sale to Elevance Health
• Beacon Health on its sale to Elevance Health
• Elevance Health on its acquisition of America’s 1st Choice
• Versant Health on its $1.7 billion sale to MetLife
• InnovAge on its sale to Apax Partners
• Humana on its $725 million acquisition of Enclara Healthcare
Pharmacy and Supply Chain
• Blackstone, Carlyle and H&F on their $34 billion acquisition of Medline
• Express Scripts on its $34 billion acquisition of Medco
• Walgreens on its $24 billion sale to Sycamore Partners
• Genoa Healthcare on its $2.5 billion sale to Optum
• CPS on its sale to Optum
• PharmScript on its sale to Optum
• Shields Health on its $2.5 billion sale to Walgreens
• Special Committee of Agiliti on its $2.5 billion sale to THL Partners
• VaxCare on its $1.7 billion sale to Blackstone
• BioPlus on its sale to Elevance Health
• CarepathRx Health System Solutions on its sale to Cigna
• ExactCare on its $570 million acquisition of Tabula Rasa HealthCare
Physician Services and Alternate Site Providers
• Special Committee of HCA on its $33 billion sale to Bain and KKR
• Cardinal Health on its $3.9 billion acquisition of GI Alliance
• Solaris Health on its $2.4 billion sale to Cardinal Health
• Summit Partners and Optum on their $2.2 billion acquisition of Sound Physicians
• OneOncology on its $2.1 billion sale to TPG and Cencora
• OneOncology on its acquisition of United Urology
• DuPage Medical Group on its $1.5 billion sale to Ares
• Springstone on its $950 million sale to Medical Properties Trust
• Physicians Endoscopy on its sale to Optum
Pharma Services
• ICON on its $12 billion acquisition of PRA Health
• PPD on its $9 billion recap with H&F and Carlyle
• Syneos Health on its $7 billion sale to Elliott, Patient Square and Veritas
• INC Research on its $7 billion merger-of-equals with inVentiv Health
• Linden Capital on its acquisition of Klick Health
• PharmaCord on its $1.5 billion sale to Permira
• ProPharma Group on its sale to Odyssey Investment Partners
• UBC, subsidiary of Express Scripts, on its sale to Avista Capital
HCIT
• MultiPlan on its $11 billion combination with Churchill Capital
• WCG Clinical on its sale to Leonard Green and Novo Holdings
• MedRisk on its sale to CVC
• MedRisk on its sale to Carlyle
• TransUnion RCM, subsidiary of TransUnion, on its $1.7 billion sale to nThrive
• Special Committee of Convey Health on its $1.1 billion sale to TPG Capital
• Kepro on its sale to CNSI
• EQT on its acquisition of Certara
• Aetion on its sale to Datavant
• Wellframe on its sale to HealthEdge Software
Mr. Muntner joined Centerview in 2016 after 16 years at Credit Suisse, where he was Co-Head of the Healthcare Group in the Americas. Before Credit Suisse, he was Vice President, Strategic Planning at Hanger Orthopedic Group. He began his career in healthcare investment banking at Alex. Brown & Sons.
Mr. Muntner graduated magna cum laude from The Pennsylvania State University with a B.S. in finance. He serves on the Board of Project Morry, a not-for-profit youth-development organization.